Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > The PhytoQuin Photosensitizer
View:
Post by Eoganacht on Jan 09, 2022 11:59pm

The PhytoQuin Photosensitizer

https://www.photo-dynamic.com/

"PhotoDynamic founder Sherri McFarland is a world leader in the chemistry of light activated molecules and their applications in human health, specializing in the design of photo-activated antimicrobials and anticancer agents. In a moment of inspiration she decided to investigate whether invasive plant species might also be a repository of photoactive agents with therapeutic potential. In fact, she reasoned, photodynamic compounds synthesized within these plants and activated by sunlight may explain the capacity of these plants to prosper in environments that they were not adapted for, including exposure to a wide variety of unfamiliar plant pathogens. Sherri took the initiative to screen some of these species in her lab at Perennia Innovation Centre in Nova Scotia, and discovered a particular plant extract with photodynamic inactivation efficacy greater than many well known single synthetic compounds. Serendipitously, this plant also had a long history of safe use and an exemplary safety profile. Since that initial discovery, extensive in vitro and in vivo animal studies have confirmed that this plant extract is truly something special, with attributes including:
 
- Potent antibacterial, antifungal and antiviral activity with exposure to visible light
- Ability to break down biofilms
- Desirable safety profile and non-irritating in animal studies
- Formulated in a shelf stable product with a minimum two year expiry
 
Additionally, PhotoDynamic was able to file two patents (composition and method) to protect this discovery and recruit a world class board of directors. After raising only $330K in equity PhotoDynamic was able to develop a prototype oral light emitting device and photoactive dental foam and to sponsor a first in human clinical study at the prestigious Forsyth Institute in Cambridge, MA. The results of that study were better than expected, with statistically significant benefits realized in the oral health of  subjects.
 
Our next ambitious step is to revolutionize oral health care starting with brace wearers by bringing them a convenient way to keep their braces clean and their gums healthy during orthodontic treatment."
Comment by Pandora on Jan 10, 2022 12:43am
10925917 20190160129 16264737     PHOTODYNAMIC INC. D932023   29706480     PHOTODYNAMIC INC. NONE 20210085993 17026659     PHOTODYNAMIC INC. Device = Assignment abstract of title for Application ...more  
Comment by gojotv! on Jan 10, 2022 12:48am
Indeed, our Dr. McFarland is truly next-level brilliant. I surmise she will win a Nobel when TLT's anti-cancer therapy rolls out and the successes start racking up. GLTA!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250